We are live on
!
Find out more
Aptevo Therapeutics
APVO
APVO
hedge funds and large institutions have $13.1M invested in Aptevo Therapeutics in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
11% less capital invested
Capital invested by funds: $14.8M → $13.1M (-$1.6M)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$665K
Puts
–
Net Calls
+$665K
Net Calls Change
-$10K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$703K |
| 2 |
6CM
683 Capital Management
New York
|
-$518K |
| 3 |
Millennium Management
New York
|
-$154K |
| 4 |
SIM
Spark Investment Management
New York
|
-$123K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$33K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Two Sigma Investments
New York
| – | -$10K | – | – |
|